Cell Processing is Considered an Integral Part of the Oncology Program

For most cancer centers, cell processing is an integral part of the oncology program. This technology is crucial to the success of a patient's treatment plan. The lab started as a support for hematopoietic stem cell transplantation programs, adapted transfusion equipment to separate red blood cells from stem cells, and processed the stem cells into plasma and other components. With the success of cellular cancer immunotherapies, the role of the cell processing laboratory has increased. HSC transplantation is a common treatment for many diseases, and it is an excellent complement to CAR T-cell therapy.

Cell processing


The facility is equipped with 12 ISO 7 clean rooms and has access to an additional three. These rooms operate at positive pressure relative to an external corridor and have a low air change rate of 20-40 hPa. Each room is outfitted with a sterile work surface and a 6" biological safety cabinet. Other equipment in the clean rooms includes a refrigerator, multiple HEPA-filtered incubators, a PC with barcode scanning, and cell separation and counting.

The global cell processing market report also includes a comprehensive business analysis of the current state of the industry, which examines innovative business growth strategies and describes critical factors such as leading manufacturers, production value, key regions, and growth rate.

The Sefia S-2000 cell processing system is a multifunctional instrument that allows an operator to automate various steps of the cell therapy manufacturing process. It has dedicated software and disposable kits that allow operators to automate the individual steps. In addition, the S-2000's high capacity and temperature-controlled environment make it the perfect choice for larger companies or biopharmaceutical research labs. In addition, it has a weight sensor and can process up to 10 L of cellular product.

Achieving high cell yields is essential for the industrialized mass production of adherent-dependent cultures. To achieve high cell recovery, manufacturers prefer optimized downstream solutions. They also emphasize the use of animal-origin raw materials. With all of this in mind, supply chain management is essential to ensure that samples reach the manufacturing facility or hospital safely. Additionally, cryopreservation, when combined with high-quality reagents, improves the effectiveness of the process.

Post a Comment

Previous Post Next Post